Olema Pharmaceuticals, Inc.
OLMA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001750284
In the last 90 days, Olema Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 185 institutions reported holding it in 13F filings for Q2 2026, worth $1.28B in total; Duquesne Family Office is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Olema Pharmaceuticals, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- −22 vs. Q4 2024
- Shares held
- 65.9M
- −5.26M (−7.4%) vs. Q4 2024
- Total value
- $248.0M
- −$166.7M (−40.2%) vs. Q4 2024
- New holders
- 25
- 47 more added
- Sold out
- 47
- 43 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OLMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 185 | $1.28B |
| Q1 2026 | 195 | $1.51B |
| Q4 2025 | 200 | $2.27B |
| Q3 2025 | 126 | $668.2M |
| Q2 2025 | 123 | $300.5M |
| Q1 2025 | 134 | $248.0M |
| Q4 2024 | 157 | $415.4M |
| Q3 2024 | 130 | $700.3M |
| Q2 2024 | 129 | $626.9M |
| Q1 2024 | 126 | $635.2M |
| Q4 2023 | 113 | $717.1M |
| Q3 2023 | 97 | $584.4M |
| Q2 2023 | 87 | $329.2M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 67 | $81.6M |
| Q3 2022 | 73 | $92.1M |
| Q2 2022 | 76 | $139.2M |
| Q1 2022 | 91 | $155.2M |
| Q4 2021 | 97 | $359.5M |
| Q3 2021 | 76 | $1.01B |
| Q2 2021 | 69 | $1.05B |
| Q1 2021 | 74 | $1.16B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Olema Pharmaceuticals, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 6,843,954 | $25.7M | 3.81% | −626,260−8.4% | Reduced |
| Paradigm Biocapital Advisors LP | 6,741,172 | $25.3M | 1.17% | −563,798−7.7% | Reduced |
| BVF Inc | 5,295,893 | $19.9M | 0.81% | −420,000−7.3% | Reduced |
| BlackRock, Inc. | 3,822,342 | $14.4M | 0.00% | +32,510+0.9% | Added |
| Deep Track Capital, LP | 3,442,833 | $12.9M | 0.42% | 00.0% | Unchanged |
| Logos Global Management LP | 3,208,875 | $12.1M | 2.14% | 00.0% | Unchanged |
| Franklin Resources Inc | 3,011,969 | $11.3M | 0.00% | +2,738,263+1,000.4% | Added |
| MPM Oncology Impact Management LP | 2,930,446 | $11.0M | 1.89% | +17,896+0.6% | Added |
| Vanguard Group Inc | 2,871,613 | $10.8M | 0.00% | +186,604+6.9% | Added |
| Lightspeed Management Company, L.L.C. | 1,930,894 | $7.26M | 5.32% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 1,879,013 | $7.07M | 0.01% | −4,341−0.2% | Reduced |
| Citadel Advisors LLC | 1,872,628 | $7.04M | 0.01% | +189,421+11.3% | Added |
| Vivo Capital, LLC | 1,505,862 | $5.66M | 0.75% | 00.0% | Unchanged |
| Woodline Partners LP | 1,477,907 | $5.56M | 0.04% | +120,428+8.9% | Added |
| Wellington Management Group LLP | 1,473,679 | $5.54M | 0.00% | −51,805−3.4% | Reduced |
| Point72 Asset Management, L.P. | 1,441,690 | $5.42M | 0.02% | −2,229,136−60.7% | Reduced |
| Dimensional Fund Advisors LP | 1,319,179 | $4.96M | 0.00% | −13,613−1.0% | Reduced |
| UBS Group AG | 1,151,147 | $4.33M | 0.00% | +590,641+105.4% | Added |
| Geode Capital Management, LLC | 1,083,126 | $4.07M | 0.00% | +156,964+16.9% | Added |
| Millennium Management LLC | 978,848 | $3.68M | 0.00% | −3710.0% | Reduced |
| Bank of America Corp | 908,548 | $3.42M | 0.00% | +43,209+5.0% | Added |
| State Street Corp | 865,556 | $3.25M | 0.00% | −991,971−53.4% | Reduced |
| Candriam Luxembourg S.C.A. | 850,517 | $3.20M | 0.02% | −701,045−45.2% | Reduced |
| Pier Capital, LLC | 817,961 | $3.08M | 0.52% | +545,589+200.3% | Added |
| Goldman Sachs Group Inc | 741,329 | $2.79M | 0.00% | +358,412+93.6% | Added |
| Schroder Investment Management Group | 533,111 | $2.19M | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 451,691 | $1.70M | 0.00% | −572,786−55.9% | Reduced |
| Northern Trust Corp | 418,085 | $1.57M | 0.00% | −5,702−1.3% | Reduced |
| Ameriprise Financial Inc | 399,799 | $1.50M | 0.00% | −49,899−11.1% | Reduced |
| BNP Paribas Arbitrage, SA | 368,104 | $1.38M | 0.00% | +174,356+90.0% | Added |
| Charles Schwab Investment Management Inc | 349,023 | $1.31M | 0.00% | +16,073+4.8% | Added |
| Nuveen, LLC | 344,296 | $1.29M | 0.00% | +344,296 | New |
| Affinity Asset Advisors, LLC | 325,000 | $1.22M | 0.19% | +325,000 | New |
| Marshall Wace, LLP | 319,950 | $1.20M | 0.00% | +127,007+65.8% | Added |
| JPMorgan Chase & Co | 286,933 | $1.08M | 0.00% | +126,182+78.5% | Added |
| Hennion & Walsh Asset Management, Inc. | 242,486 | $911.7K | 0.04% | +30,240+14.2% | Added |
| HighVista Strategies LLC | 212,185 | $797.8K | 0.31% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 191,994 | $721.9K | 0.24% | +100,000+108.7% | Added |
| Susquehanna Fundamental Investments, LLC | 175,448 | $659.7K | 0.01% | +164,472+1,498.5% | Added |
| Barclays PLC | 153,104 | $575.7K | 0.00% | +38,225+33.3% | Added |
| Jane Street Group, LLC | 138,552 | $521.0K | 0.00% | +94,815+216.8% | Added |
| Two Sigma Advisers, LP | 138,000 | $518.9K | 0.00% | +49,000+55.1% | Added |
| Bank of New York Mellon Corp | 131,994 | $496.3K | 0.00% | +3,328+2.6% | Added |
| Balyasny Asset Management LLC | 113,018 | $424.9K | 0.00% | −1,014,571−90.0% | Reduced |
| Dana Investment Advisors, Inc. | 112,954 | $424.7K | 0.02% | +20,915+22.7% | Added |
| Diadema Partners LP | 100,000 | $376.0K | 0.30% | +100,000 | New |
| Cubist Systematic Strategies, LLC | 93,669 | $352.2K | 0.00% | +67,682+260.4% | Added |
| Victory Capital Management Inc | 92,310 | $347.1K | 0.00% | −790−0.8% | Reduced |
| Walleye Capital LLC | 87,705 | $329.8K | 0.00% | +20,698+30.9% | Added |
| Jacobs Levy Equity Management, Inc | 74,919 | $281.7K | 0.00% | 00.0% | Unchanged |
| PDT Partners, LLC | 74,299 | $279.4K | 0.02% | +74,299 | New |
| Susquehanna International Group, LLP | 71,788 | $269.9K | 0.00% | +5,568+8.4% | Added |
| Oxford Asset Management LLP | 68,974 | $259.3K | 0.12% | +68,974 | New |
| Renaissance Technologies LLC | 64,600 | $242.9K | 0.00% | −92,700−58.9% | Reduced |
| Two Sigma Investments, LP | 62,926 | $236.6K | 0.00% | −9,951−13.7% | Reduced |
| Rhumbline Advisers | 58,055 | $218.3K | 0.00% | −378−0.6% | Reduced |
| Boothbay Fund Management, LLC | 57,824 | $217.4K | 0.01% | +26,598+85.2% | Added |
| LPL Financial LLC | 55,959 | $210.4K | 0.00% | +55,959 | New |
| Deutsche Bank AG | 54,329 | $204.3K | 0.00% | +14,998+38.1% | Added |
| Invesco Ltd. | 50,810 | $191.0K | 0.00% | +34,362+208.9% | Added |
| Alps Advisors Inc | 50,484 | $189.8K | 0.00% | +4,149+9.0% | Added |
| Portland Investment Counsel Inc. | 50,000 | $188.0K | 0.06% | +25,000+100.0% | Added |
| EP Wealth Advisors, LLC | 48,249 | $181.4K | 0.00% | −406−0.8% | Reduced |
| Envestnet Asset Management Inc | 46,699 | $175.6K | 0.00% | −3,363−6.7% | Reduced |
| Graham Capital Management, L.P. | 46,510 | $174.9K | 0.01% | +46,510 | New |
| AQR Capital Management LLC | 45,661 | $171.7K | 0.00% | +45,661 | New |
| Alliancebernstein L.P. | 44,620 | $167.8K | 0.00% | −269,362−85.8% | Reduced |
| Citigroup Inc | 30,991 | $116.5K | 0.00% | −37,005−54.4% | Reduced |
| Verition Fund Management LLC | 25,125 | $94.5K | 0.00% | −4,515−15.2% | Reduced |
| Virtus Investment Advisers, Inc. | 24,427 | $91.8K | 0.02% | +24,427 | New |
| Intech Investment Management LLC | 24,312 | $91.4K | 0.00% | +6,570+37.0% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 23,932 | $90.0K | 0.00% | −2,284−8.7% | Reduced |
| Wells Fargo & Company | 23,239 | $87.4K | 0.00% | +514+2.3% | Added |
| Persistent Asset Partners Ltd | 22,988 | $86.4K | 0.08% | +22,988 | New |
| Squarepoint Ops LLC | 22,933 | $86.2K | 0.00% | −25,896−53.0% | Reduced |
| Royal Bank of Canada | 21,939 | $83.0K | 0.00% | −1,179−5.1% | Reduced |
| Corton Capital Inc. | 21,741 | $81.7K | 0.27% | +4,433+25.6% | Added |
| Corebridge Financial, Inc. | 20,026 | $75.3K | 0.00% | −296−1.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 20,020 | $75.3K | 0.00% | −485,380−96.0% | Reduced |
| Skopos Labs, Inc. | 18,915 | $71.1K | 0.02% | +18,915 | New |
| MetLife Investment Management | 17,675 | $66.5K | 0.00% | −6,020−25.4% | Reduced |
| Price T Rowe Associates Inc | 17,536 | $66.0K | 0.00% | −8,576−32.8% | Reduced |
| HSBC Holdings PLC | 15,698 | $57.8K | 0.00% | +5,693+56.9% | Added |
| Manufacturers Life Insurance Company, The | 15,296 | $57.5K | 0.00% | +172+1.1% | Added |
| China Universal Asset Management Co., Ltd. | 14,892 | $56.0K | 0.01% | +2,743+22.6% | Added |
| Susquehanna Portfolio Strategies, LLC | 14,125 | $53.1K | 0.02% | +14,125 | New |
| SG Americas Securities, LLC | 14,193 | $53.0K | 0.00% | −3,282−18.8% | Reduced |
| Alpine Global Management, LLC | 13,874 | $52.2K | 0.01% | +13,874 | New |
| J. Goldman & Co LP | 13,500 | $50.8K | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 13,499 | $50.8K | 0.01% | +13,499 | New |
| Pitcairn Co | 12,532 | $47.1K | 0.00% | −11,496−47.8% | Reduced |
| Jain Global LLC | 12,396 | $46.6K | 0.00% | +12,396 | New |
| Group One Trading, L.P. | 12,199 | $45.9K | 0.00% | +12,199 | New |
| ProShare Advisors LLC | 12,197 | $45.9K | 0.00% | −2,029−14.3% | Reduced |
| Quarry LP | 12,000 | $45.1K | 0.01% | +12,000 | New |
| Voya Investment Management LLC | 11,779 | $44.3K | 0.00% | −744−5.9% | Reduced |
| Sanctuary Advisors, LLC | 11,334 | $42.6K | 0.00% | +11,334 | New |
| Y-Intercept (Hong Kong) Ltd | 10,882 | $40.9K | 0.00% | −8,119−42.7% | Reduced |
| Conway Capital Management, Inc. | 10,000 | $37.6K | 0.02% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 8,868 | $33.3K | 0.00% | 00.0% | Unchanged |